Clinical Trial Update: Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT) [Phase 2]

View source ↗

Summary

This clinical trial update indicates that a Phase 2 study of iberdomide in people with multiple myeloma who have previously undergone autologous hematopoietic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• iberdomide (iberdomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING